openPR Logo
Press release

Antipsychotic Drugs Market Analysis By Industry Size, Share, Revenue Growth Demand and Forecast - 2031

11-28-2024 03:56 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Antipsychotic Drugs Market

Antipsychotic Drugs Market

The global antipsychotic drugs market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Antipsychotic drugs are medications used to treat psychological disorders such as schizophrenia and bipolar disorder. Psychosis is a critical symptom that occurs due to mental illness, including loss with reality affecting how one processes information. Though, on contrary to the general perception, the possibility of men and women being affected by bipolar disorder is similar. Thus, the surge in the cases of the disease among females as well as males coupled with the rising need to manage the disease effectively is projected to lead to the demand for these drugs, thereby augmenting the growth of the global antipsychotic drugs market.

Get Free Sample link @ https://www.omrglobal.com/request-sample/antipsychotic-drugs-market

With the shifting perspective of the global population toward mental health, there is an increased demand for diagnosis and treatment of various mental disorders. Bipolar disorder, being one such prevalent issue, which is anticipated to spur its drugs market. As per the Institute for Health Metrics and Evaluation (IHME), Global Burden of Diseases, the prevalence of bipolar disorder across the world varies from 0.3 to 1.2% by country. In 2017 around 46 million people in the world had bipolar disorder, with 52% and 48% being female and male, respectively. The typical age of onset is the late teens or the early 20s, and a history of depression is common in people diagnosed with bipolar disorder. However, the high cost associated with the treatment of these mental issues is expected to hamper the market growth.

Full report of Antipsychotic Drugs Market available @ https://www.omrglobal.com/industry-reports/antipsychotic-drugs-market

Market Coverage

Segment Covered-
o By Application

o By Drug Classification

Regions covered-
o North America

o Europe

o Asia-Pacific

o Rest of the World

Competitive Landscape: Pfizer Inc., Eli Lilly & Co., and AstraZeneca plc, among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How are players addressing challenges to sustain growth?
Where is the investment opportunity?

Global Antipsychotic Drugs Market Report by Segment

By Application

Dementia
Bipolar Disorder
Schizophrenia
Dementia
Others

By Drug Classification

First Generation (Typical)
Second Generation (Atypical)
Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antipsychotic-drugs-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antipsychotic Drugs Market Analysis By Industry Size, Share, Revenue Growth Demand and Forecast - 2031 here

News-ID: 3762287 • Views:

More Releases from Orion Market Research

Fiber Optic Ferrule Market Analysis Current Landscape and Future Outlook
Fiber Optic Ferrule Market Analysis Current Landscape and Future Outlook
The global Fiber Optic Ferrule Market was valued at approximately USD 2.5 billion in 2024 and is projected to reach USD 4.8 billion by 2033, expanding at a Compound Annual Growth Rate (CAGR) of 8.5% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/fiber-optic-ferrule-market Fiber Optic Ferrule Market Overview: The Fiber Optic Ferrule Market is driven by the increasing demand for high-speed internet and reliable communication networks. Ferrules are
Edge Gateway Market Size Unlocking New Opportunities for Success
Edge Gateway Market Size Unlocking New Opportunities for Success
The global Edge Gateway Market was valued at approximately USD 6.1 billion in 2023 and is projected to reach USD 34.5 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 18.2% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/edge-gateway-market Edge Gateway Market Overview: The Edge Gateway Market is experiencing rapid growth due to the increasing need for real-time data processing and the expansion of the
Transitional Care Management (TCM) Services Market Rising Demand and Growth Forecast Through 2033
Transitional Care Management (TCM) Services Market Rising Demand and Growth Fore …
The Transitional Care Management (TCM) Services Market is projected to be valued at approximately USD 3.9 billion in 2024 and is expected to reach around USD 8.3 billion by 2033, growing at a Compound Annual Growth Rate (CAGR) of 8.8% from 2025 to 2033. Transitional Care Management (TCM) Services Market Overview The Transitional Care Management (TCM) Services Market is experiencing rapid growth as healthcare providers focus on improving patient outcomes during transitions
Medicinal Mushroom Extract Market Analysis Current Landscape and Future Outlook
Medicinal Mushroom Extract Market Analysis Current Landscape and Future Outlook
The global Medicinal Mushroom Extract Market was valued at approximately USD 11.59 billion in 2023 and is projected to reach USD 19.05 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 5.58% from 2024 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/medicinal-mushroom-extract-market Medicinal Mushroom Extract Market Overview: The medicinal mushroom extract market is witnessing significant growth due to the increasing demand for natural health products and functional

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug